| Primary information |
|---|
| ID | 11749 |
| Uniprot ID | P84935 |
| Description | [Val1;Hyp2;Thr6]-bradykinyl-Gln;Ser ([Val1;Hyp2;Thr6]-bradykinin-Gln;Ser) |
| Organism | Pithecopus azureus |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amphibia; Batrachia; Anura; Neobatrachia; Hyloidea; Hylidae (tree frogs); Phyllomedusinae; Pithecopus; Pithecopus azureus (Orange-legged monkey tree frog) (Phyllomedusa azurea) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the bradykinin-related peptide family. |
| Tissue Specificity | Expressed by the skin glands. |
| Post Translational Modification | NA |
| Function | May produce in vitro relaxation of rat arterial smooth muscle and constriction of intestinal smooth muscle. May target bradykinin receptors (BDKRB). |
| Length | 11 |
| Molecular Weight | 1 |
| Name | [Val1;Hyp2;Thr6]-bradykinyl-Gln;Ser ([Val1;Hyp2;Thr6]-bradykinin-Gln;Ser) |
| Sequence | VPPGFTPFRQS |
| Sequence map | 11 |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|